Corbus Pharmaceuticals Holdings, Inc. (CRBP) News
Track canonical SquawkNews coverage tagged to CRBP, Corbus Pharmaceuticals Holdings, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
CRBP - Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
CRBP - Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
EARNINGS | Aug 06, 2026, 12:00 PM UTC
M
Corbus Pharmaceuticals Completes CANYON-1 Study
Corbus completes obesity treatment study
EQUITY | Aug 04, 2026, 12:31 PM UTC
L
Corbus Pharmaceuticals announces FDA clearance to initiate TEMPO-1 trial
Corbus Pharmaceuticals...
EQUITY | Jul 28, 2026, 01:12 PM UTC
L
CRBP Corbus Pharmaceuticals announces FDA clearance to initiate tempo-1 registrational study of crb-701 in patients with 2l oropharyngeal ca
CRBP Corbus Pharmaceuticals announces FDA clearance to initiate tempo-1 registrational study of crb-701 in patients with 2l oropharyngeal cancer Corbus Pharmaceuticals announces FDA clearance to initiate tempo-1 registra
REGULATION | Jul 28, 2026, 12:00 PM UTC
L
Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
NORWOOD, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (
EQUITY | Jul 06, 2026, 12:01 PM UTC